Simplex Trading
ORIC icon

Simplex Trading’s Oric Pharmaceuticals ORIC Stock Holding History

Simplex Trading’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17.1K Buy
1,348
+852
+172% +$9.67K ﹤0.01% 6895
2025
Q4 		$4.06K Buy
+496
New +$5.71K ﹤0.01% 7540
2025
Q2 		– Sell
-146
Closed -$980 – 9449
2025
Q1 		$0 Buy
+146
New +$1.28K ﹤0.01% 9334
2024
Q1 		– Sell
-163
Closed -$1.94K – 9580
2023
Q4 		$1K Buy
+163
New +$1.18K ﹤0.01% 8549
2023
Q3 		– Sell
-29,017
Closed -$238K – 9502
2023
Q2 		$225K Buy
29,017
+28,630
+7,398% +$163K ﹤0.01% 4171
2023
Q1 		$2K Sell
387
-3,797
-91% -$19.8K ﹤0.01% 8501
2022
Q4 		$24K Sell
4,184
-5,937
-59% -$20K ﹤0.01% 6700
2022
Q3 		$32K Buy
10,121
+1,824
+22% +$7.3K ﹤0.01% 6994
2022
Q2 		$37K Buy
8,297
+6,445
+348% +$25.7K ﹤0.01% 6884
2022
Q1 		$9K Buy
+1,852
New +$16.7K ﹤0.01% 8966
2021
Q4 		– Sell
-116
Closed -$1.81K – 11158
2021
Q3 		$2K Hold
116
– – ﹤0.01% 9550
2021
Q2 		$2K Buy
+116
New +$2.54K ﹤0.01% 9729

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Simplex Trading's ORIC Position: Q1 2026 in Review

Simplex Trading increased its Oric Pharmaceuticals (ORIC) stake by 172% in Q1 2026, buying an estimated $9.67K and bringing the position to 1,348 shares worth $17.1K. The position accounts for ﹤0.01% of the portfolio, ranked #6895.

Simplex Trading first reported a position in ORIC in Q2 2021 and has held it in 12 quarters since. The position peaked at $225K in Q2 2023. 182 funds tracked by Wall St. Rank hold ORIC as of Q1 2026.

  • Simplex Trading held 1,348 shares of Oric Pharmaceuticals worth $17.1K as of Q1 2026.
  • Simplex Trading bought 852 Oric Pharmaceuticals shares in Q1 2026, an estimated $9.67K.
  • Oric Pharmaceuticals made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #6895 holding.
  • Simplex Trading first reported a position in Oric Pharmaceuticals in Q2 2021 and has held it in 12 quarters since.
  • Simplex Trading's Oric Pharmaceuticals position peaked at $225K in Q2 2023.
  • 182 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.